To investigate a possible dysregulation of the autoantibody network in AIDS patients, the relative activity of representative natural antibodies was measured in serum IgG and IgM. These immunoglobulins were purified from two cohorts of 20 HIV-infected patients undergoing, or not, a triple combination therapy. A cohort of 20 normal patients was used as a control. Marked alterations of the natural antibody repertoire were observed, varying according to the isotype and specificity of the antibody studied. For the classical self-protein antigens, human actin and myosin, the changes observed in the untreated cohort were absent in the treated cohort. In contrast, no changes, or even increased changes of the activity of antibodies to special antigens, DNA and TNP, occurred in the treated cohort. The differences were highly significant, indicating that this repertoire is regulated and not randomly modified by the disease. These results suggest the presence of different factors of dysregulation of the B cell repertoire of natural antibodies associated with the disease as well as with the treatment. These major dysregulations may favor the autoimmune phenomena observed during HIV infection.
Introduction
Normal human serum contains polyspecific antibodies that recognize structures of self-components conserved during evolution [1, 2] . The role of these unconventional antibodies is still a matter of debate, but they are likely to represent a modern form of primordial molecules involved in the clearance of degraded autologous antigens, such as actin and myosin [3] . The polyspecificity of natural antibodies allows the binding of cross-reactive foreign antigens, including HIV components [4, 5] , leading to an initial immune barrier against micro-organisms [6] . This protection has been recently demonstrated in mice [7] . Natural IgM antibodies can also react with idiotopes of immunoglobulins and control the autoreactivity of IgG [8, 9] . The repertoire of natural antibodies involves a limited subset of autoantibodies and is stable during aging [10] . It also includes antibodies to artificial haptens, such as TNP, and immunoglobulins reacting with DNA by unclear mechanisms [11] . In AIDS patients, an increased level of many natural antibodies was reported in the crude serum [12] . Recently, it has been shown that the increase of some autoantibodies is potentially pathogenic during this disease [13] . These abnormalities are in agreement with the relationship already observed between AIDS and autoimmune phenomena [14] [15] [16] [17] [18] .
To analyze this dysregulation in HIV patients and its possible changes under treatment, irrespective of IgM-IgG idiotypic interactions, we investigated natural antibodies against representative antigens in purified serum IgG and IgM from treated and untreated patients. Our results show that the dysregulation of the natural antibody network is complex in these patients, as compared with a cohort of normal subjects, and varies under treatment according to the nature of the antigen.
Subjects and Methods
Two different cohorts of 20 HIV-infected patients were selected for the presence, or absence of triple combination therapy (two reverse transcriptase inhibitors and one protease inhibitor). At the time of examination, their clinical and biological data were varied, but the differences between the two corresponding cohorts predominated in their viral load, as measured using the Amplicor Roche assay, whereas similar numbers of CD4 + cells were detected using flow cytometry (Tables 1 and 2 ). Two patients (P7 and P45) were investigated before and after treatment. A cohort of 20 healthy donors served as a control group.
Human actin and myosin, TNP-Ovalbumin and DNA were prepared as already described [19] . To avoid reciprocal anti-idiotypic interactions between the IgG and IgM isotypes [8, 9] , serum IgG was purified by absorption onto a protein G-Sepharose sorbent (Pharmacia, Uppsala, Sweden) and eluted with a pH 2.6, 0.2 M glycine-HCl buffer. The unbound material was shown to be IgG depleted and was investigated with an anti-chain antibody. The remaining IgA was not taken into account since idiotypic interactions with this isotype have only been observed in the fetus [19] . Determination in triplicate of the concentration of purified IgG and IgM and of the binding activity of natural antibodies was carried out by ELISA, as already described [19] . Dilutions of a pool of 100 normal human sera of known IgG and IgM concentrations were used for the corresponding reference curves, and IgG and IgM preparations from this pool served as internal controls for natural antibody assays. The antibody values obtained from this pool may differ from those of the normal human distribution since corresponding to mean and not to median values and because of inter-individual idiotypic interferences. Relative activities were expressed as an antibody coefficient determined by the following formula:
where the optical density at 490 nm of the antibody was measured at the same immunoglobulin concentration in the assayed and in the control pool preparations. Calculations were carried out from values taken within the linear segment of the reference curve. In relation with the non-Gaussian distribution of the antibody levels, results were expressed as median values and quartiles, and the comparisons were carried out with the U-test of Mann and Whitney. The probabilities were calculated according to two-tailed values in all comparisons, except in the case of IgG anti-human myosin where the one-tailed method was allowed by the same variations as those of the IgG anti-human actin. For the two individual subjects (P7 and P45), the antibody variation was expressed as the ratio of the antibody coefficient before and after treatment. A linear correlation was investigated between this ratio and the ratio of the corresponding median values of the cohorts of untreated and treated patients. Correlations of the natural antibody levels with the CD4 + cell count were investigated with the Spearman correlation coefficient. Statistics were carried out by using the StatView SE+graphicsy program.
Results

Different antibody levels in untreated patients and in controls
Comparison of the antibody coefficient in the IgG and IgM fractions showed statistically marked variations between untreated patients and normal subjects (Figures 1 and 2 ). These variations depended with the isotype and the specificity of the antibody. The levels of IgG antibodies to human antigens were lower (actin: P≤0.0001; myosin: P one-tailed ≤0.37) in the untreated patients, whereas their IgM counterpart was higher (actin: P≤0.017; myosin: P one-tailed ≤0.05) than in the control subjects ( Figure 1 ). In contrast, except for IgM anti-DNA, both IgG and IgM antibody levels to DNA and TNP were lower in the patients, with P values varying from 0.017 to 0.0007 ( Figure 2 ).
Normal levels of antibodies to human antigens in the treated patients
No statistical difference was observed between the levels of both IgG and IgM antibodies to human actin and myosin in the treated patients and in the control subjects, the P values varying between 0.13 and 0.87 ( Figure 1) . Accordingly, significant differences were observed in most cases between the corresponding antibody levels in the IgG and IgM fractions of the treated and untreated patients (Figure 1 ).
Abnormal levels of antibodies to DNA and TNP in the treated patients
In contrast with the recovery of a normal pattern of antibodies to the self proteins, major differences were observed between antibodies to DNA and TNP in the treated subjects as compared with the normal controls ( Figure 2) . In some cases, these differences were even 
Statistical significance and follow-up of two individual patients
The statistical analysis of our results showed a high proportion (16 out of 24) of significant differences when comparing the three cohorts. These differences were thus non-randomly distributed, and the method used was adapted to a much smaller number of subjects. Moreover, the changes observed between the treated and the untreated patients were significant even when investigating the evolution of only two individual patients (Table 3 ). Additional comparison of the values of natural antibodies with the number of CD4 + cells in all patients showed no correlation; P values varying from 0.30 to 0.98.
Discussion
Major dysregulations of natural antibody levels have been observed in this study in the absence of IgG-IgM idiotypic interactions. Recovery of a normal pattern of antibodies to self proteins occurred following therapy, whereas variable and marked changes of the levels of antibodies to DNA and TNP were observed in the treated patients. The non-random nature of these variations confirms that the repertoire of natural antibodies is regulated and suggests that the HIV disease modifies this regulation by specific mechanisms. Alterations of the natural antibody repertoire have been described in various diseases, such as the hyperIgM syndrome [20] , systemic lupus erythematosis [21] , and warm autoimmune anemia [22] . These alterations are mostly in relation with a defective control of the autoantibody reactivity by autologous IgM/IgG anti-idiotypes. This mechanism cannot explain our results which concern separated IgG and IgM isotypes. The dysregulation may be associated with a CD4 + T cell defect, but the count of these cells was similar in untreated and treated patients. It is more likely associated with the selective defect of V H 3 + B cells and of the secondary V H 3 + circulating IgG observed in the blood of AIDS patients [22] [23] [24] . In these patients, the partial recovery of V H 3 + B cells under treatment may restore a normal network of natural autoantibodies. The recovery of a normal pattern of antibodies toward peptidic autoantigens, observed both at the cohort level and in the two individual patients, demonstrates the efficacy of the treatment on the regulation of the classical natural repertoire of B cells. It is in agreement with the gradual reduction of B cell abnormalities during antiretroviral therapy in AIDS patients [25] . The lack of recovery to normal levels of antibodies to DNA and TNP in treated patients indicates that these antibodies are not regulated by the mechanisms associated with antibodies to actin and myosin. This difference may be related to the special significance of these antibodies. Indeed, the DNA-anti-DNA binding seems to differ from the classical antigen-antibody interactions by mainly involving simple ionic charges via the acid phosphate residues of DNA and the high number of basic amino acids described in the corresponding antibodies [11] . Concerning the natural antibodies to TNP, these molecules may not be considered as true autoantibodies because TNP, as an artificial hapten, is not present in the body. The dysregulations observed with these antibodies seem thus to be associated not only with the infection but also with the treatment itself. In the case of true autoantibodies and of special antibodies, the lack of correlation of the antibody levels with the number of CD4 + cells, is in favor of mechanisms independent from the severity of the disease.
Since natural antibodies are primarily directed against self antigens, the observed dysregulations may be involved in the various abnormalities of autoantibodies and autoimmunity reported during AIDS and HIV-associated diseases [14] [15] [16] [17] [18] . These abnormalities include the presence of serum antibodies against phospholipids [26, 27] , antineutrophil cytoplasmic autoantibodies [28, 29] , antibodies to HLA [30] , anti-glomerular basement antibodies [29] , anti-various nuclear antigens and DNA [28, 31, 32] , anti-denatured collagen [33] , and rheumatoid factor [34] . It is thus conceivable that the high frequency of these autoimmune phenomena is favored by dysregulations of the natural antibody network described here.
It is likely that the dysregulations of natural antibodies interfere with the functions of the first immune barrier against cross-reactive infectious agents and of the basic autoimmune survey. The maintenance of this network is a constant feature of the B cell repertoire as early as during the intra-uterine age, and therefore its dysregulation in HIV-infected patients is obviously of biological importance. *Antibody coefficient before treatment/antibody coefficient after treatment×100. †Median value of the cohort of untreated patients/median value of the cohort of treated patients×100.
